BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 29567577)

  • 1. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
    Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
    Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
    Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
    J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
    Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
    J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
    Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differing phenotypes of Moyamoya disease in a familial case involving heterozygous c.14429G > A variant in RNF213.
    Inoue T; Murakami N; Sakadume S; Kido Y; Kikuchi A; Ichinoi N; Suzuki K; Kure S; Sakuta R
    Pediatr Int; 2015 Aug; 57(4):798-801. PubMed ID: 26315205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF213 p.R4810K Polymorphism and the Risk of Moyamoya Disease, Intracranial Major Artery Stenosis/Occlusion, and Quasi-Moyamoya Disease: A Meta-Analysis.
    Wang Y; Mambiya M; Li Q; Yang L; Jia H; Han Y; Liu W
    J Stroke Cerebrovasc Dis; 2018 Aug; 27(8):2259-2270. PubMed ID: 29752070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
    Liao X; Deng J; Dai W; Zhang T; Yan J
    Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare and Low-Frequency Variants in RNF213 Confer Susceptibility to Moyamoya Syndrome Associated with Hyperthyroidism.
    Nomura S; Akagawa H; Yamaguchi K; Ishikawa T; Kawashima A; Kasuya H; Mukawa M; Nariai T; Maehara T; Okada Y; Kawamata T
    World Neurosurg; 2019 Jul; 127():e460-e466. PubMed ID: 30922903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Moyamoya Disease Susceptibility Gene Affect Extracranial Systemic Artery Stenosis?
    Nomura S; Aihara Y; Akagawa H; Chiba K; Yamaguchi K; Kawashima A; Okada Y; Kawamata T
    J Stroke Cerebrovasc Dis; 2020 Feb; 29(2):104532. PubMed ID: 31806452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
    Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
    J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNF213 vasculopathy manifested in various forms within a family: A case report.
    Lim SS; Park S; Oh BH; Jung K; Bae JW; Bae DH
    Medicine (Baltimore); 2023 Dec; 102(50):e36627. PubMed ID: 38115307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different phenotypes of moyamoya disease in a Chinese familial case involving heterozygous c.14429G>a variant in RNF213.
    Li F; Huang YY; Zhang S; Wang W
    Br J Neurosurg; 2023 Dec; 37(6):1882-1885. PubMed ID: 35642380
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Ok T; Jung YH; Kim J; Park SK; Park G; Lee S; Lee KY
    J Am Heart Assoc; 2022 Aug; 11(15):e025676. PubMed ID: 35876407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis of RNF213 p.R4810K variant in non-moyamoya intracranial artery stenosis/occlusion disease in a Chinese population.
    Zhang T; Guo C; Liao X; Xia J; Wang X; Deng J; Yan J
    Environ Health Prev Med; 2017 Apr; 22(1):41. PubMed ID: 29165136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
    Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the
    Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY
    J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between moyamoya syndrome and the RNF213 c.14576G>A variant in patients with neurofibromatosis Type 1.
    Phi JH; Choi JW; Seong MW; Kim T; Moon YJ; Lee J; Koh EJ; Ryu SK; Kang TH; Bang JS; Oh CW; Park SS; Lee JY; Wang KC; Kim SK
    J Neurosurg Pediatr; 2016 Jun; 17(6):717-22. PubMed ID: 26849809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic Validation of RNF213 Coding Variants in Japanese Patients With Moyamoya Disease.
    Moteki Y; Onda H; Kasuya H; Yoneyama T; Okada Y; Hirota K; Mukawa M; Nariai T; Mitani S; Akagawa H
    J Am Heart Assoc; 2015 May; 4(5):. PubMed ID: 25964206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset of moyamoya syndrome in a Down syndrome patient with the genetic variant RNF213 p.R4810K.
    Chong PF; Ogata R; Kobayashi H; Koizumi A; Kira R
    Brain Dev; 2015 Sep; 37(8):822-4. PubMed ID: 25547042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renovascular hypertension and
    Kim JY; Cho H
    Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.